On November 16, Rocket Lab USA, Inc. fell 4.05% Overnight, trading at $59.03 per share, with Turnover of $7.2951 million.
The move coincided with continued market digestion of the company’s weaker-than-expected third-quarter profitability, modest analyst target-price cuts, and lingering uncertainty around its proposed roughly $8 billion acquisition of Iridium Communications.
Recent disclosures showed third-quarter revenue rose 73% year over year to $267.8 million, above expectations, while per-share loss came in at $0.12, worse than expected. Morgan Stanley trimmed its price target to $103 from $105 and Needham lowered its target to $100, though both remained constructive. Options activity also pointed to capped-upside positioning, including a roughly $1.05 million far-out-of-the-money call sale. Separately, Rocket Lab recently completed its 100th Electron launch, but the overnight move suggests investors remain focused on earnings quality and deal-related execution risk.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments